---
figid: PMC2731267__WJG-14-4434-g001
figlink: /pmc/articles/PMC2731267/figure/F1/
number: F1
caption: Some putative molecular mechanisms that underlie the antineoplastic activity
  of mesalazine. Mesalazine inhibits COX-2, thereby blocking synthesis of PGH2, an
  intermediate that is metabolized into various prostaglandins, including PGE2. PGE2
  binds to its cell surface cognate receptors (EP1-4) and sustains various functions
  of tumor cells, including proliferation, survival, angiogenesis and invasion. These
  are mediated through the transactivation of EGFR or activation of other intracellular
  pathways. The antineoplastic effects of mesalazine rely also on its ability to inhibit
  Wnt/β-catenin, through inactivation of PP2A (and downstream down-regulation of β-catenin),
  and EGFR pathways. Moreover, mesalazine activates PPAR-γ, thus leading to inactivation
  of the Wnt/β-catenin pathway and down-regulation of COX-2.
pmcid: PMC2731267
papertitle: Molecular basis of the potential of mesalazine to prevent colorectal cancer.
reftext: Carmine Stolfi, et al. World J Gastroenterol. 2008 Jul 28;14(28):4434-4439.
pmc_ranked_result_index: '34243'
pathway_score: 0.8983612
filename: WJG-14-4434-g001.jpg
figtitle: Some putative molecular mechanisms that underlie the antineoplastic activity
  of mesalazine
year: '2008'
organisms: Homo sapiens
ndex: ada42dcb-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2731267__WJG-14-4434-g001.html
  '@type': Dataset
  description: Some putative molecular mechanisms that underlie the antineoplastic
    activity of mesalazine. Mesalazine inhibits COX-2, thereby blocking synthesis
    of PGH2, an intermediate that is metabolized into various prostaglandins, including
    PGE2. PGE2 binds to its cell surface cognate receptors (EP1-4) and sustains various
    functions of tumor cells, including proliferation, survival, angiogenesis and
    invasion. These are mediated through the transactivation of EGFR or activation
    of other intracellular pathways. The antineoplastic effects of mesalazine rely
    also on its ability to inhibit Wnt/β-catenin, through inactivation of PP2A (and
    downstream down-regulation of β-catenin), and EGFR pathways. Moreover, mesalazine
    activates PPAR-γ, thus leading to inactivation of the Wnt/β-catenin pathway and
    down-regulation of COX-2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - EGF
  - PTPN11
  - AREG
  - EGR3
  - EGFR
  - PPARG
  - FZD4
  - FZD6
  - BTC
  - EPGN
  - EGR1
  - GSK3B
  - TGFA
  - HBEGF
  - FZD10
  - EGR4
  - EREG
  - PPARA
  - PPARD
  - FZD2
  - FZD7
  - FZD5
  - FZD8
  - PTPN14
  - EGR2
  - GSK3A
  - FZD9
  - FZD1
  - FZD3
genes:
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: EGF,
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: SH-PTP2
  symbol: SH-PTP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: EGR
  symbol: EGR
  source: bioentities_symbol
  hgnc_symbol: EGR3
  entrez: '1960'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARG
  entrez: '5468'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: BTC
  entrez: '685'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EPGN
  entrez: '255324'
- word: EGR
  symbol: EGR
  source: bioentities_symbol
  hgnc_symbol: EGR1
  entrez: '1958'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: TGF-a)
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: EGR
  symbol: EGR
  source: bioentities_symbol
  hgnc_symbol: EGR4
  entrez: '1961'
- word: EGFRligands
  symbol: EGFR_ligand
  source: bioentities_symbol
  hgnc_symbol: EREG
  entrez: '2069'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: PPAR
  symbol: PPAR
  source: bioentities_symbol
  hgnc_symbol: PPARD
  entrez: '5467'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: PEZ
  symbol: PEZ
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN14
  entrez: '5784'
- word: EGR
  symbol: EGR
  source: bioentities_symbol
  hgnc_symbol: EGR2
  entrez: '1959'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FRIZZLED
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
chemicals: []
diseases: []
figid_alias: PMC2731267__F1
redirect_from: /figures/PMC2731267__F1
figtype: Figure
---
